Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective
This comprehensive review offers a detailed look at atopic dermatitis (AD) treatment in Italy, focusing primarily on the use of biologics and small molecules. In response to advancing knowledge of AD's causes and treatments, there's a global need for updated guidelines to provide physician...
Saved in:
Main Authors: | Alba Guglielmo (Author), Maria Ludovica Deotto (Author), Luigi Naldi (Author), Giuseppe Stinco (Author), Alessandro Pileri (Author), Bianca Maria Piraccini (Author), Anna Belloni Fortina (Author), Andrea Sechi (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real‐life case‐series experience with tralokinumab in patients with severe atopic dermatitis
by: Francesca Caroppo, et al.
Published: (2024) -
Burden of Disease in Real-Life Setting of Patients With Atopic Dermatitis: Italian Data From the MEASURE-AD Study
by: Giuseppe Argenziano, et al.
Published: (2024) -
Comorbidities in pediatric atopic dermatitis
by: Eliza I Pope, et al.
Published: (2018) -
A Case of Lip Psoriasis in a 14-Year-Old Boy Successfully Treated with Adalimumab
by: Francesca Caroppo, et al.
Published: (2023) -
Atopic dermatitis: Update on comorbidities and therapeutic advances
by: Katie Kim, et al.
Published: (2019)